{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:16:03Z","timestamp":1787667363769,"version":"build-2736575974"},"reference-count":171,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010823","name":"Tore Nilson Foundation for Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004348","name":"Stockholms L\u00e4ns Landsting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ejim.2025.04.034","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T15:50:09Z","timestamp":1746460209000},"page":"11-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Drug-induced hyponatremia in clinical care"],"prefix":"10.1016","volume":"137","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5789-8470","authenticated-orcid":false,"given":"Buster","family":"Mannheimer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7198-7269","authenticated-orcid":false,"given":"Jonatan D.","family":"Lindh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0763-7739","authenticated-orcid":false,"given":"Cecilia Bergh","family":"Fahl\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7239-9407","authenticated-orcid":false,"given":"Issa","family":"Issa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5622-6987","authenticated-orcid":false,"given":"Henrik","family":"Falhammar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3738-1367","authenticated-orcid":false,"given":"Jakob","family":"Skov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10 Suppl 1","key":"10.1016\/j.ejim.2025.04.034_bib0001","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.amjmed.2013.07.006","article-title":"Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations","volume":"126","author":"Verbalis","year":"2013","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.ejim.2025.04.034_bib0002","first-page":"370","article-title":"Hyponatraemia diagnosis and treatment clinical practice guidelines","volume":"37","author":"Spasovski","year":"2017","journal-title":"Nefrologia (Engl Ed)"},{"issue":"2","key":"10.1016\/j.ejim.2025.04.034_bib0003","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejim.2012.10.014","article-title":"Epidemiology and characteristics of hyponatremia in the emergency department","volume":"24","author":"Olsson","year":"2013","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2025.04.034_bib0004","doi-asserted-by":"crossref","DOI":"10.1007\/s00228-020-03086-6","article-title":"Association between newly initiated thiazide diuretics and hospitalization due to hyponatremia","author":"Mannheimer","year":"2021","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.ejim.2025.04.034_bib0005","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1053\/j.ajkd.2008.03.004","article-title":"A review of drug-induced hyponatremia","volume":"52","author":"Liamis","year":"2008","journal-title":"Am J Kidney Dis"},{"issue":"13","key":"10.1016\/j.ejim.2025.04.034_bib0006","first-page":"1269","article-title":"Disorders of plasma sodium","volume":"372","author":"Sterns","year":"2015","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.ejim.2025.04.034_bib0007","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11195810","article-title":"Pathophysiology of Drug-Induced Hyponatremia","volume":"11","author":"Kim","year":"2022","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.ejim.2025.04.034_bib0008","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1093\/ndt\/gfm714","article-title":"Fluoxetine effect on kidney water reabsorption","volume":"23","author":"Moyses","year":"2008","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1016\/j.ejim.2025.04.034_bib0009","doi-asserted-by":"crossref","first-page":"F963","DOI":"10.1152\/ajprenal.00576.2020","article-title":"Psychotropic drugs upregulate aquaporin-2 via vasopressin-2 receptor\/cAMP\/protein kinase A signaling in inner medullary collecting duct cells","volume":"320","author":"Kim","year":"2021","journal-title":"Am J Physiol Renal Physiol"},{"issue":"9","key":"10.1016\/j.ejim.2025.04.034_bib0010","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/ene.13069","article-title":"Epidemiology, pathophysiology and putative genetic basis of carbamazepine- and oxcarbazepine-induced hyponatremia","volume":"23","author":"Berghuis","year":"2016","journal-title":"Eur J Neurol"},{"issue":"9","key":"10.1016\/j.ejim.2025.04.034_bib0011","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1172\/JCI89812","article-title":"Phenotypic and pharmacogenetic evaluation of patients with thiazide-induced hyponatremia","volume":"127","author":"Ware","year":"2017","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.ejim.2025.04.034_bib0012","doi-asserted-by":"crossref","first-page":"24","DOI":"10.7326\/0003-4819-110-1-24","article-title":"Thiazide-induced hyponatremia. Reproducibility by single dose rechallenge and an analysis of pathogenesis","volume":"110","author":"Friedman","year":"1989","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.ejim.2025.04.034_bib0013","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/HJH.0000000000000423","article-title":"Thiazide-induced hyponatraemia is associated with increased water intake and impaired urea-mediated water excretion at low plasma antidiuretic hormone and urine aquaporin-2","volume":"33","author":"Frenkel","year":"2015","journal-title":"J Hypertens"},{"issue":"2","key":"10.1016\/j.ejim.2025.04.034_bib0014","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1053\/j.ajkd.2019.07.011","article-title":"Thiazide-Associated Hyponatremia: Clinical Manifestations and Pathophysiology","volume":"75","author":"Filippone","year":"2020","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"10.1016\/j.ejim.2025.04.034_bib0015","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1210\/clinem\/dgae352","article-title":"The Effect of Thiazide Diuretics on Urinary Prostaglandin E2 Excretion and Serum Sodium in the General Population","volume":"109","author":"Geurts","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.ejim.2025.04.034_bib0016","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s40618-018-0984-z","article-title":"Endocrine and metabolic adverse effects of immune checkpoint inhibitors: an overview (what endocrinologists should know)","volume":"42","author":"Ruggeri","year":"2019","journal-title":"J Endocrinol Invest"},{"issue":"8","key":"10.1016\/j.ejim.2025.04.034_bib0017","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/SMJ.0b013e3181e63682","article-title":"Cisplatin-induced renal salt wasting syndrome","volume":"103","author":"Hamdi","year":"2010","journal-title":"South Med J"},{"issue":"10","key":"10.1016\/j.ejim.2025.04.034_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002930","article-title":"Desmopressin and the risk of hyponatremia: A population-based cohort study","volume":"16","author":"Fralick","year":"2019","journal-title":"PLoS Med"},{"issue":"2","key":"10.1016\/j.ejim.2025.04.034_bib0019","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00431-013-2108-2","article-title":"Pharmacokinetics of desmopressin administered as tablet and oral lyophilisate formulation in children with monosymptomatic nocturnal enuresis","volume":"173","author":"De Bruyne","year":"2014","journal-title":"Eur J Pediatr"},{"issue":"1","key":"10.1016\/j.ejim.2025.04.034_bib0020","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1210\/jcem-63-1-129","article-title":"Antidiuretic effect and pharmacokinetics of oral 1-desamino-8-D-arginine vasopressin. 1. Studies in adults and children","volume":"63","author":"Williams","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ejim.2025.04.034_bib0021","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/nau.20168","article-title":"Desmopressin treatment in nocturia; an analysis of risk factors for hyponatremia","volume":"25","author":"Rembratt","year":"2006","journal-title":"Neurourol Urodyn"},{"issue":"6","key":"10.1016\/j.ejim.2025.04.034_bib0022","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s00228-022-03297-z","article-title":"Desmopressin therapy in children and adults: pharmacological considerations and clinical implications","volume":"78","author":"Chin","year":"2022","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.ejim.2025.04.034_bib0023","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/jgh3.12254","article-title":"A retrospective analysis of hyponatremia during terlipressin treatment in patients with esophageal or gastric variceal bleeding due to portal hypertension","volume":"4","author":"Han","year":"2020","journal-title":"JGH Open"},{"issue":"3","key":"10.1016\/j.ejim.2025.04.034_bib0024","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/ijgo.15939","article-title":"Severe hyponatremia in obstetrics: Presentations and outcome. Retrospective cohort over 10\u2009years","volume":"168","author":"Elbarbary","year":"2025","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"10.1016\/j.ejim.2025.04.034_bib0025","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/jama.1958.02990020025004","article-title":"Treatment of essential hypertension with chlorothiazide (diuril); its use alone and combined with other antihypertensive agents","volume":"166","author":"Freis","year":"1958","journal-title":"J Am Med Assoc"},{"issue":"11","key":"10.1016\/j.ejim.2025.04.034_bib0026","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.amjmed.2011.06.031","article-title":"Risk of thiazide-induced hyponatremia in patients with hypertension","volume":"124","author":"Leung","year":"2011","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.ejim.2025.04.034_bib0027","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/0002-9343(81)90822-6","article-title":"Thiazide-induced hyponatremia associated with death or neurologic damage in outpatients","volume":"70","author":"Ashraf","year":"1981","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.ejim.2025.04.034_bib0028","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1053\/j.ajkd.2013.02.365","article-title":"Thiazide-associated hyponatremia: a population-based study","volume":"62","author":"Rodenburg","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.ejim.2025.04.034_bib0029","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2125.2005.02531.x","article-title":"Thiazide diuretic prescription and electrolyte abnormalities in primary care","volume":"61","author":"Clayton","year":"2006","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.ejim.2025.04.034_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/M23-1989","article-title":"Cumulative Incidence of Thiazide-Induced Hyponatremia : A Population-Based Cohort Study","volume":"177","author":"Andersson","year":"2024","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.ejim.2025.04.034_bib0031","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/qjmed\/hcg157","article-title":"Risk factors for thiazide-induced hyponatraemia","volume":"96","author":"Chow","year":"2003","journal-title":"QJM"},{"issue":"3","key":"10.1016\/j.ejim.2025.04.034_bib0032","doi-asserted-by":"crossref","DOI":"10.1093\/ageing\/afad026","article-title":"The differential risk of severe hyponatraemia based on the use patterns of hyponatraemia-inducing medications in older adults","volume":"52","author":"Jun","year":"2023","journal-title":"Age Ageing"},{"issue":"3","key":"10.1016\/j.ejim.2025.04.034_bib0033","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/cen.14497","article-title":"Non-thiazide diuretics and hospitalization due to hyponatraemia: A population-based case-control study","volume":"95","author":"Mannheimer","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"10.1016\/j.ejim.2025.04.034_bib0034","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.amjcard.2004.04.059","article-title":"Usefulness of spironolactone in a specialized heart failure clinic","volume":"94","author":"Sligl","year":"2004","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.ejim.2025.04.034_bib0035","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0735-1097(02)02694-3","article-title":"Complications of inappropriate use of spironolactone in heart failure: when an old medicine spirals out of new guidelines","volume":"41","author":"Bozkurt","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"10008","key":"10.1016\/j.ejim.2025.04.034_bib0036","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(15)00257-3","article-title":"Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial","volume":"386","author":"Williams","year":"2015","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ejim.2025.04.034_bib0037","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1023\/A:1007708831545","article-title":"Hyponatremia and amlodipine therapy","volume":"13","author":"Malaterre","year":"1999","journal-title":"Cardiovasc Drugs Ther"},{"issue":"6","key":"10.1016\/j.ejim.2025.04.034_bib0038","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1002\/cpt.1562","article-title":"Severe Hyponatremia Is Often Drug Induced: 10-Year Results of a Prospective Pharmacovigilance Program","volume":"106","author":"Ram\u00edrez","year":"2019","journal-title":"Clin Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.ejim.2025.04.034_bib0039","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1001\/archinte.1995.00430090099011","article-title":"Risk factors for the development of hyponatremia in psychiatric inpatients","volume":"155","author":"Siegler","year":"1995","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.ejim.2025.04.034_bib0040","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1067\/mcp.2002.124520","article-title":"Angiotensin-converting enzyme inhibitor-induced syndrome of inappropriate secretion of antidiuretic hormone: case report and review of the literature","volume":"71","author":"Izzedine","year":"2002","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.ejim.2025.04.034_bib0041","doi-asserted-by":"crossref","DOI":"10.1177\/1470320319834409","article-title":"Syndrome of inappropriate secretion of antidiuretic hormone associated with angiotensin-converting enzyme inhibitor therapy in the perioperative period","volume":"20","author":"Nakayama","year":"2019","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.ejim.2025.04.034_bib0042","first-page":"2009","article-title":"Severe hyponatraemia during therapy with ramipril","author":"Ramasamy","year":"2009","journal-title":"BMJ Case Rep"},{"issue":"4","key":"10.1016\/j.ejim.2025.04.034_bib0043","doi-asserted-by":"crossref","first-page":"219","DOI":"10.4103\/0976-500X.171880","article-title":"A case of losartan-induced severe hyponatremia","volume":"6","author":"Das","year":"2015","journal-title":"J Pharmacol Pharmacother"},{"issue":"3","key":"10.1016\/j.ejim.2025.04.034_bib0044","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.archger.2014.08.002","article-title":"Severe hyponatremia in older patients at admission in an internal medicine department","volume":"59","author":"Correia","year":"2014","journal-title":"Arch Gerontol Geriatr"},{"key":"10.1016\/j.ejim.2025.04.034_bib0045","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa194","article-title":"Associations between antihypertensive medications and severe hyponatremia: A Swedish population-based case-control study","author":"Falhammar","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ejim.2025.04.034_bib0046","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.psym.2014.01.010","article-title":"Antidepressants and the risk of hyponatremia: a class-by-class review of literature","volume":"55","author":"De Picker","year":"2014","journal-title":"Psychosomatics"},{"key":"10.1016\/j.ejim.2025.04.034_bib0047","first-page":"377","article-title":"Antidepressant Use Among Adults: United States, 2015\u20132018","author":"Laura","year":"2020","journal-title":"NCHS Data Brief"},{"issue":"6","key":"10.1016\/j.ejim.2025.04.034_bib0048","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/JCP.0000000000000608","article-title":"Antidepressant-Associated Hyponatremia in the Elderly","volume":"36","author":"Greenblatt","year":"2016","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.ejim.2025.04.034_bib0049","doi-asserted-by":"crossref","first-page":"d4551","DOI":"10.1136\/bmj.d4551","article-title":"Antidepressant use and risk of adverse outcomes in older people: population based cohort study","volume":"343","author":"Coupland","year":"2011","journal-title":"BMJ (Clinical research ed)"},{"issue":"1","key":"10.1016\/j.ejim.2025.04.034_bib0050","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1053\/j.ajkd.2016.08.020","article-title":"Second-Generation Antidepressants and Hyponatremia Risk: A Population-Based Cohort Study of Older Adults","volume":"69","author":"Gandhi","year":"2017","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.ejim.2025.04.034_bib0051","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1017\/S1461145711001192","article-title":"Hyponatraemia during psychopharmacological treatment: results of a drug surveillance programme","volume":"15","author":"Letmaier","year":"2012","journal-title":"The international journal of neuropsychopharmacology \/official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP)"},{"issue":"5","key":"10.1016\/j.ejim.2025.04.034_bib0052","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-011200","article-title":"Antidepressants and the risk of hyponatremia: a Danish register-based population study","volume":"6","author":"Leth-Moller","year":"2016","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.ejim.2025.04.034_bib0053","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.amjmed.2017.07.025","article-title":"Differences in Associations of Antidepressants and Hospitalization Due to Hyponatremia","volume":"131","author":"Farmand","year":"2018","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.ejim.2025.04.034_bib0054","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1046\/j.1365-2125.1999.00872.x","article-title":"Incidence and risk factors for hyponatraemia following treatment with fluoxetine or paroxetine in elderly people","volume":"47","author":"Wilkinson","year":"1999","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.ejim.2025.04.034_bib0055","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/archinte.164.3.327","article-title":"Paroxetine-induced hyponatremia in older adults: a 12-week prospective study","volume":"164","author":"Fabian","year":"2004","journal-title":"Arch Intern Med"},{"issue":"8","key":"10.1016\/j.ejim.2025.04.034_bib0056","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1177\/02698811211001082","article-title":"Time-dependent association between selective serotonin reuptake inhibitors and hospitalization due to hyponatremia","volume":"35","author":"Mannheimer","year":"2021","journal-title":"J Psychopharmacol"},{"issue":"1","key":"10.1016\/j.ejim.2025.04.034_bib0057","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1192\/j.eurpsy.2024.11","article-title":"The risk of antidepressant-induced hyponatremia: A meta-analysis of antidepressant classes and compounds","volume":"67","author":"Gheysens","year":"2024","journal-title":"Eur Psychiatry"},{"issue":"3","key":"10.1016\/j.ejim.2025.04.034_bib0058","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1528-1157.1984.tb04205.x","article-title":"Carbamazepine and serum sodium levels","volume":"25","author":"Kalff","year":"1984","journal-title":"Epilepsia"},{"issue":"12","key":"10.1016\/j.ejim.2025.04.034_bib0059","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1212\/01.wnl.0000188819.45330.90","article-title":"Hyponatremia from oxcarbazepine and carbamazepine","volume":"65","author":"Dong","year":"2005","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.ejim.2025.04.034_bib0060","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.seizure.2013.11.015","article-title":"Frequency of and risk factors for oxcarbazepine-induced severe and symptomatic hyponatremia","volume":"23","author":"Kim","year":"2014","journal-title":"Seizure"},{"issue":"1","key":"10.1016\/j.ejim.2025.04.034_bib0061","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1055\/s-2002-33046","article-title":"Some common issues in the use of antiepileptic drugs","volume":"22","author":"Asconape","year":"2002","journal-title":"Semin Neurol"},{"issue":"2","key":"10.1016\/j.ejim.2025.04.034_bib0062","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.seizure.2013.11.002","article-title":"Use of oxcarbazepine for treatment of refractory status epilepticus","volume":"23","author":"Kellinghaus","year":"2014","journal-title":"Seizure"},{"issue":"7","key":"10.1016\/j.ejim.2025.04.034_bib0063","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/epi.13777","article-title":"Carbamazepine- and oxcarbazepine-induced hyponatremia in people with epilepsy","volume":"58","author":"Berghuis","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejim.2025.04.034_bib0064","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.seizure.2019.10.013","article-title":"Prevalence and risk factors for hyponatremia in adult epilepsy patients: Large-scale cross-sectional cohort study","volume":"73","author":"Yamamoto","year":"2019","journal-title":"Seizure"},{"issue":"8","key":"10.1016\/j.ejim.2025.04.034_bib0065","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/jnnp.41.8.713","article-title":"Water intoxication in epileptic patients receiving carbamazepine","volume":"41","author":"Perucca","year":"1978","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6053","key":"10.1016\/j.ejim.2025.04.034_bib0066","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/bmj.1.6053.83-a","article-title":"Hyponatraemia during carbamazepine treatment","volume":"1","author":"Henry","year":"1977","journal-title":"Br Med J"},{"issue":"2","key":"10.1016\/j.ejim.2025.04.034_bib0067","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0278-5846(94)90055-8","article-title":"Review of carbamazepine-induced hyponatremia","volume":"18","author":"Gandelman","year":"1994","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"12","key":"10.1016\/j.ejim.2025.04.034_bib0068","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1111\/epi.13593","article-title":"Antiepileptic drugs and hyponatremia in older adults: Two population-based cohort studies","volume":"57","author":"Gandhi","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejim.2025.04.034_bib0069","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.seizure.2018.04.025","article-title":"Differences in associations of antiepileptic drugs and hospitalization due to hyponatremia: A population-based case-control study","volume":"59","author":"Falhammar","year":"2018","journal-title":"Seizure"},{"issue":"1","key":"10.1016\/j.ejim.2025.04.034_bib0070","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.japh.2020.09.015","article-title":"National trends in prescription proton pump inhibitor use and expenditure in the United States in 2002-2017","volume":"61","author":"Mishuk","year":"2021","journal-title":"Journal of the American Pharmacists Association"},{"issue":"4","key":"10.1016\/j.ejim.2025.04.034_bib0071","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.nefro.2017.03.021","article-title":"Hyponatraemia diagnosis and treatment clinical practice guidelines","volume":"37","author":"Spasovski","year":"2017","journal-title":"Nefrologia"},{"issue":"21","key":"10.1016\/j.ejim.2025.04.034_bib0072","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1056\/NEJM200005253422107","volume":"342","author":"Adrogue","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2025.04.034_bib0073","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejim.2018.08.012","article-title":"Associations of proton pump inhibitors and hospitalization due to hyponatremia: A population-based case-control study","volume":"59","author":"Falhammar","year":"2019","journal-title":"Eur J Intern Med"},{"issue":"1","key":"10.1016\/j.ejim.2025.04.034_bib0074","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13256-020-02423-8","article-title":"Omeprazole-induced and pantoprazole-induced asymptomatic hyponatremia: a case report","volume":"14","author":"van der Zalm","year":"2020","journal-title":"J Med Case Rep"},{"issue":"4","key":"10.1016\/j.ejim.2025.04.034_bib0075","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/1753495X221113489","article-title":"Severe hyponatraemia peripartum associated with omeprazole therapy","volume":"16","author":"Morton","year":"2023","journal-title":"Obstet Med"},{"issue":"1","key":"10.1016\/j.ejim.2025.04.034_bib0076","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2302\/kjm.2020-0008-CR","article-title":"Syndrome of Inappropriate Secretion of Antidiuretic Hormone Caused by Very Short-term Use of Proton Pump Inhibitor","volume":"70","author":"Aratani","year":"2021","journal-title":"Keio J Med"},{"issue":"11","key":"10.1016\/j.ejim.2025.04.034_bib0077","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1111\/jgs.12534","article-title":"Risk of proton pump inhibitor-induced mild hyponatremia in older adults","volume":"61","author":"Buon","year":"2013","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"10.1016\/j.ejim.2025.04.034_bib0078","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1038\/s41598-019-39335-7","article-title":"Analysis of postmarketing safety data for proton-pump inhibitors reveals increased propensity for renal injury, electrolyte abnormalities, and nephrolithiasis","volume":"9","author":"Makunts","year":"2019","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ejim.2025.04.034_bib0079","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00228-022-03423-x","article-title":"Mannheimer B. Time-dependent association between omeprazole and esomeprazole and hospitalization due to hyponatremia","volume":"79","author":"Issa","year":"2023","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.ejim.2025.04.034_bib0080","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/JCP.0b013e318218f446","article-title":"Psychotropic medication use, hyponatremia, and falls in an inpatient population: a retrospective study","volume":"31","author":"Bun","year":"2011","journal-title":"J Clin Psychopharmacol"},{"issue":"7","key":"10.1016\/j.ejim.2025.04.034_bib0081","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2165\/11532560-000000000-00000","article-title":"Hyponatraemia as an adverse drug reaction of antipsychotic drugs: a case-control study in VigiBase","volume":"33","author":"Mannesse","year":"2010","journal-title":"Drug Saf"},{"key":"10.1016\/j.ejim.2025.04.034_bib0082","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40697-016-0111-z","article-title":"Atypical antipsychotic medications and hyponatremia in older adults: a population-based cohort study","volume":"3","author":"Gandhi","year":"2016","journal-title":"Can J Kidney Health Dis"},{"issue":"5","key":"10.1016\/j.ejim.2025.04.034_bib0083","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s00213-017-4525-9","article-title":"Antipsychotic use is a risk factor for hyponatremia in patients with schizophrenia: a 15-year follow-up study","volume":"234","author":"Yang","year":"2017","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/j.ejim.2025.04.034_bib0084","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2165\/11319070-000000000-00000","article-title":"Antipsychotic-induced hyponatraemia: a systematic review of the published evidence","volume":"33","author":"Meulendijks","year":"2010","journal-title":"Drug Saf"},{"key":"10.1016\/j.ejim.2025.04.034_bib0085","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejim.2018.11.011","article-title":"Antipsychotics and severe hyponatremia: A Swedish population-based case-control study","volume":"60","author":"Falhammar","year":"2019","journal-title":"Eur J Intern Med"},{"issue":"1","key":"10.1016\/j.ejim.2025.04.034_bib0086","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.psychres.2012.01.022","article-title":"Correll CU. Medical outcome of psychiatric inpatients with admission hyponatremia","volume":"198","author":"Manu","year":"2012","journal-title":"Psychiatry Res"},{"issue":"1","key":"10.1016\/j.ejim.2025.04.034_bib0087","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0022-3565(25)11227-5","article-title":"Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic","volume":"260","author":"Raffa","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ejim.2025.04.034_bib0088","series-title":"Goodman and Gilman\u2019s The Pharmacological Basis of Therapeutics","first-page":"2011","author":"Brunton","year":"2011"},{"issue":"4","key":"10.1016\/j.ejim.2025.04.034_bib0089","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.amjmed.2014.10.046","article-title":"Azoulay L. Tramadol for noncancer pain and the risk of hyponatremia","volume":"128","author":"Fournier","year":"2015","journal-title":"Am J Med"},{"key":"10.1016\/j.ejim.2025.04.034_bib0090","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ejim.2019.08.006","article-title":"Tramadol- and codeine-induced severe hyponatremia: A Swedish population-based case-control study","volume":"69","author":"Falhammar","year":"2019","journal-title":"Eur J Intern Med"},{"issue":"3","key":"10.1016\/j.ejim.2025.04.034_bib0091","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s40268-023-00436-4","article-title":"Risk of Hyponatremia after Tramadol\/Acetaminophen Single-Pill Combination Therapy: A Real-World Study Based on the OMOP-CDM Database","volume":"23","author":"Lee","year":"2023","journal-title":"Drugs R D"},{"issue":"2","key":"10.1016\/j.ejim.2025.04.034_bib0092","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/bcp.14401","article-title":"Can tramadol really induce hyponatraemia? A pharmacovigilance study","volume":"87","author":"de Canecaude","year":"2021","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.ejim.2025.04.034_bib0093","doi-asserted-by":"crossref","first-page":"222","DOI":"10.14283\/jfa.2019.18","article-title":"Drug-Induced Hyponatremia: NSAIDs, a Neglected Cause that Should Be Considered","volume":"8","author":"Damanti","year":"2019","journal-title":"J Frailty Aging"},{"issue":"4","key":"10.1016\/j.ejim.2025.04.034_bib0094","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.kint.2020.05.015","article-title":"Rondon-Berrios H. Hyponatremia in the cancer patient","volume":"98","author":"Workeneh","year":"2020","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.ejim.2025.04.034_bib0095","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1001\/archinte.1973.03650110061013","article-title":"Vincristine neurotoxicity and abnormal secretion of antidiuretic hormone","volume":"132","author":"Robertson","year":"1973","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.ejim.2025.04.034_bib0096","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1182\/blood.V45.3.315.315","article-title":"Syndrome of recurrent increased secretion of antidiuretic hormone following multiple doses of vincristine","volume":"45","author":"Stuart","year":"1975","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.ejim.2025.04.034_bib0097","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1345\/aph.1R296","article-title":"Syndrome of inappropriate antidiuretic hormone secretion induced by a single dose of oral cyclophosphamide","volume":"46","author":"Gilbar","year":"2012","journal-title":"Ann Pharmacother"},{"issue":"14","key":"10.1016\/j.ejim.2025.04.034_bib0098","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1016\/S0959-8049(97)00329-8","article-title":"Recurrent ifosfamide-induced hyponatraemia","volume":"33","author":"Kirch","year":"1997","journal-title":"Eur J Cancer"},{"issue":"8","key":"10.1016\/j.ejim.2025.04.034_bib0099","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1136\/thx.39.8.636","article-title":"Syndrome of inappropriate antidiuretic hormone secretion due to treatment of lung cancer with cisplatin","volume":"39","author":"Littlewood","year":"1984","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.ejim.2025.04.034_bib0100","first-page":"531","article-title":"Syndrome of inappropriate secretion of anti-diuretic hormone following carboplatin-paclitaxel administration in a patient with recurrent ovarian cancer","volume":"26","author":"Yokoyama","year":"2005","journal-title":"Eur J Gynaecol Oncol"},{"issue":"2","key":"10.1016\/j.ejim.2025.04.034_bib0101","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1681\/ASN.2019070676","article-title":"Clinical Features and Outcomes of Immune Checkpoint Inhibitor-Associated AKI: A Multicenter Study","volume":"31","author":"Cortazar","year":"2020","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.ejim.2025.04.034_bib0102","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000455014","article-title":"Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review","volume":"45","author":"Wanchoo","year":"2017","journal-title":"Am J Nephrol"},{"issue":"9","key":"10.1016\/j.ejim.2025.04.034_bib0103","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1056\/NEJMra1807486","article-title":"Adrenal Crisis","volume":"381","author":"Rushworth","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2025.04.034_bib0104","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.102974","article-title":"Electrolyte disorders in advanced non-small cell lung cancer patients treated with immune check-point inhibitors: A systematic review and meta-analysis","volume":"151","author":"Cantini","year":"2020","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"10.1016\/j.ejim.2025.04.034_bib0105","first-page":"108","article-title":"Programmed cell death protein 1 inhibitor treatment is associated with acute kidney injury and hypocalcemia: meta-analysis. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association","volume":"34","author":"Manohar","year":"2019","journal-title":"European Renal Association"},{"issue":"12","key":"10.1016\/j.ejim.2025.04.034_bib0106","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1093\/ndt\/gfaa272","article-title":"Hyponatremia and other electrolyte abnormalities in patients receiving immune checkpoint inhibitors","volume":"36","author":"Seethapathy","year":"2021","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.ejim.2025.04.034_bib0107","doi-asserted-by":"crossref","first-page":"296","DOI":"10.7326\/0003-4819-119-4-199308150-00008","article-title":"Renal mechanism of trimethoprim-induced hyperkalemia","volume":"119","author":"Vel\u00e1zquez","year":"1993","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.ejim.2025.04.034_bib0108","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.amjmed.2016.07.012","article-title":"Incidence of Hyponatremia with High-Dose Trimethoprim-Sulfamethoxazole Exposure","volume":"129","author":"Tsapepas","year":"2016","journal-title":"Am J Med"},{"issue":"9","key":"10.1016\/j.ejim.2025.04.034_bib0109","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1111\/jcpt.13679","article-title":"Impact of trimethoprim on serum creatinine, sodium, and potassium concentrations in patients taking trimethoprim-sulfamethoxazole without changes in glomerular filtration rate","volume":"47","author":"Yokoyama","year":"2022","journal-title":"J Clin Pharm Ther"},{"issue":"1","key":"10.1016\/j.ejim.2025.04.034_bib0110","doi-asserted-by":"crossref","first-page":"38","DOI":"10.11150\/kansenshogakuzasshi1970.82.38","article-title":"[Marked hyponatremia with consciousness disturbance probably caused by linezolid in a patient with acute myeloid leukemia]","volume":"82","author":"Suzuki","year":"2008","journal-title":"Kansenshogaku Zasshi"},{"issue":"21","key":"10.1016\/j.ejim.2025.04.034_bib0111","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.2146\/ajhp150208","article-title":"A probable case of syndrome of inappropriate antidiuretic hormone secretion associated with linezolid","volume":"72","author":"Baik","year":"2015","journal-title":"Am J Health Syst Pharm"},{"issue":"3","key":"10.1016\/j.ejim.2025.04.034_bib0112","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/jcpt.12681","article-title":"A case of severe hyponatremia due to linezolid-induced SIADH","volume":"43","author":"Ioannou","year":"2018","journal-title":"J Clin Pharm Ther"},{"issue":"2","key":"10.1016\/j.ejim.2025.04.034_bib0113","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/jcpt.13069","article-title":"Linezolid-induced rare triad of hypoglycaemia, bone marrow suppression and hyponatraemia in elderly","volume":"45","author":"Singhania","year":"2020","journal-title":"J Clin Pharm Ther"},{"issue":"10","key":"10.1016\/j.ejim.2025.04.034_bib0114","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1248\/bpb.b23-00038","article-title":"Comparison of Incidence of Hyponatremia between Linezolid and Vancomycin by Propensity Score Matching Analysis","volume":"46","author":"Tanaka","year":"2023","journal-title":"Biol Pharm Bull"},{"issue":"2","key":"10.1016\/j.ejim.2025.04.034_bib0115","article-title":"Electrolyte and Acid-Base Disorders Triggered by Aminoglycoside or Colistin Therapy: A Systematic Review","volume":"10","author":"Scoglio","year":"2021","journal-title":"Antibiotics (Basel)"},{"issue":"1","key":"10.1016\/j.ejim.2025.04.034_bib0116","article-title":"Syndrome of inappropriate antidiuretic hormone secretion as an adverse reaction of ciprofloxacin: a case report and literature review","volume":"34","author":"\u0160vitek","year":"2024","journal-title":"Biochem Med (Zagreb)"},{"issue":"8","key":"10.1016\/j.ejim.2025.04.034_bib0117","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJM198702193160807","article-title":"Amiodarone","volume":"316","author":"Mason","year":"1987","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ejim.2025.04.034_bib0118","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1177\/08971900211054199","article-title":"Amiodarone-Induced Hyponatremia in An Elderly Patient: A Rare Case Report","volume":"36","author":"Mahadevappa","year":"2023","journal-title":"J Pharm Pract"},{"issue":"3","key":"10.1016\/j.ejim.2025.04.034_bib0119","first-page":"125","article-title":"Amiodarone-induced syndrome of inappropriate antidiuresis with hepatic transaminitis","volume":"28","author":"Saito","year":"2023","journal-title":"J Cardiol Cases"},{"issue":"5","key":"10.1016\/j.ejim.2025.04.034_bib0120","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/cvr\/cvae047","article-title":"SGLT2 inhibitors: from glucose-lowering to cardiovascular benefits","volume":"120","author":"Preda","year":"2024","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ejim.2025.04.034_bib0121","first-page":"2022","article-title":"Canagliflozin-associated severe hyponatremia: a rare and potentially adverse effect?","author":"Dhanasekaran","year":"2022","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"4","key":"10.1016\/j.ejim.2025.04.034_bib0122","doi-asserted-by":"crossref","DOI":"10.3390\/ph17040420","article-title":"Acute Kidney Injury and Electrolyte Imbalances Caused by Dapagliflozin Short-Term Use","volume":"17","author":"Lopes","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"issue":"2","key":"10.1016\/j.ejim.2025.04.034_bib0123","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1681\/ASN.2022050623","article-title":"Treatment Effect of the SGLT2 Inhibitor Empagliflozin on Chronic Syndrome of Inappropriate Antidiuresis: Results of a Randomized, Double-Blind, Placebo-Controlled, Crossover Trial","volume":"34","author":"Refardt","year":"2023","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.ejim.2025.04.034_bib0124","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1681\/ASN.2019090944","article-title":"A Randomized Trial of Empagliflozin to Increase Plasma Sodium Levels in Patients with the Syndrome of Inappropriate Antidiuresis","volume":"31","author":"Refardt","year":"2020","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.ejim.2025.04.034_bib0125","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jchf.2022.01.019","article-title":"Relationship of Dapagliflozin With Serum Sodium: Findings From the DAPA-HF Trial","volume":"10","author":"Yeoh","year":"2022","journal-title":"JACC Heart Fail"},{"issue":"2","key":"10.1016\/j.ejim.2025.04.034_bib0126","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1378\/chest.103.2.601","article-title":"Diuretic-induced severe hyponatremia. Review and analysis of 129 reported patients","volume":"103","author":"Sonnenblick","year":"1993","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.ejim.2025.04.034_bib0127","doi-asserted-by":"crossref","first-page":"F958","DOI":"10.1152\/ajprenal.00476.2015","article-title":"Everything we always wanted to know about furosemide but were afraid to ask","volume":"310","author":"Huang","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"issue":"1","key":"10.1016\/j.ejim.2025.04.034_bib0128","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s40360-020-00431-4","article-title":"Furosemide and spironolactone doses and hyponatremia in patients with heart failure","volume":"21","author":"Velat","year":"2020","journal-title":"BMC Pharmacol Toxicol"},{"issue":"6","key":"10.1016\/j.ejim.2025.04.034_bib0129","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.semnephrol.2011.09.010","article-title":"Diuretic-associated hyponatremia","volume":"31","author":"Hix","year":"2011","journal-title":"Semin Nephrol"},{"issue":"12","key":"10.1016\/j.ejim.2025.04.034_bib0130","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1016\/j.ajem.2020.01.009","article-title":"Dysnatremias in emergency patients with acute kidney injury: A cross-sectional analysis","volume":"38","author":"Woitok","year":"2020","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ejim.2025.04.034_bib0131","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1741-7015-11-83","article-title":"Impact of diuretic therapy-associated electrolyte disorders present on admission to the emergency department: a cross-sectional analysis","volume":"11","author":"Arampatzis","year":"2013","journal-title":"BMC Med"},{"issue":"6","key":"10.1016\/j.ejim.2025.04.034_bib0132","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJM198102053040605","article-title":"Treatment of the syndrome of inappropriate secretion of antidiuretic hormone with furosemide","volume":"304","author":"Decaux","year":"1981","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"10.1016\/j.ejim.2025.04.034_bib0133","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1093\/ndt\/gfu040","article-title":"Clinical practice guideline on diagnosis and treatment of hyponatraemia","volume":"29","author":"Spasovski","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"10.1016\/j.ejim.2025.04.034_bib0134","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1056\/NEJM197502202920803","article-title":"Treatment of the syndrome of inappropriate secretion of antidiuretic hormone with lithium carbonate","volume":"292","author":"White","year":"1975","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.ejim.2025.04.034_bib0135","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nrneph.2015.89","article-title":"Pathophysiology, diagnosis and management of nephrogenic diabetes insipidus","volume":"11","author":"Bockenhauer","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ejim.2025.04.034_bib0136","article-title":"Reduced risk for hospitalization due to hyponatraemia in lithium treated patients: A Swedish population-based case-control study","author":"Falhammar","year":"2020","journal-title":"J Psychopharmacol"},{"issue":"2","key":"10.1016\/j.ejim.2025.04.034_bib0137","doi-asserted-by":"crossref","first-page":"F309","DOI":"10.1152\/ajprenal.00001.2011","article-title":"Simvastatin enhances aquaporin-2 surface expression and urinary concentration in vasopressin-deficient Brattleboro rats through modulation of Rho GTPase","volume":"301","author":"Li","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"issue":"11","key":"10.1016\/j.ejim.2025.04.034_bib0138","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.amjmed.2017.05.030","article-title":"Elevated High-Density Lipoprotein Cholesterol Is Associated with Hyponatremia in Hypertensive Patients","volume":"130","author":"Israel","year":"2017","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.ejim.2025.04.034_bib0139","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/jcpt.13123","article-title":"Development of a hyponatremia screening tool (ABCDF-S score) for patients with hypertension using thiazide diuretic agents","volume":"45","author":"Kanchanasurakit","year":"2020","journal-title":"J Clin Pharm Ther"},{"issue":"5","key":"10.1016\/j.ejim.2025.04.034_bib0140","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00228-020-03006-8","article-title":"Association between lipid-lowering agents and severe hyponatremia: a population-based case-control study","volume":"77","author":"Skov","year":"2021","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.ejim.2025.04.034_bib0141","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/bcp.12499","article-title":"A systematic review and meta-analysis of thiazide-induced hyponatraemia: time to reconsider electrolyte monitoring regimens after thiazide initiation?","volume":"79","author":"Barber","year":"2015","journal-title":"Br J Clin Pharmacol"},{"issue":"11","key":"10.1016\/j.ejim.2025.04.034_bib0142","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.2165\/11593980-000000000-00000","article-title":"Biochemical monitoring of patients treated with antihypertensive therapy for adverse drug reactions: a systematic review","volume":"34","author":"McDowell","year":"2011","journal-title":"Drug Saf"},{"issue":"3","key":"10.1016\/j.ejim.2025.04.034_bib0143","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1258\/jrsm.2012.120137","article-title":"A practical guide to monitoring for adverse drug reactions during antihypertensive drug therapy","volume":"106","author":"McDowell","year":"2013","journal-title":"J R Soc Med"},{"issue":"8","key":"10.1016\/j.ejim.2025.04.034_bib0144","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/qjmed\/hcl071","article-title":"Severe hyponatraemia in medical in-patients: aetiology, assessment and outcome","volume":"99","author":"Clayton","year":"2006","journal-title":"QJM"},{"issue":"8","key":"10.1016\/j.ejim.2025.04.034_bib0145","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s00702-021-02369-1","article-title":"Psychotropic drug-induced hyponatremia: results from a drug surveillance program-an update","volume":"128","author":"Seifert","year":"2021","journal-title":"J Neural Transm (Vienna)"},{"issue":"3","key":"10.1016\/j.ejim.2025.04.034_bib0146","article-title":"Multifactorial Hyponatremia: Don't Miss Ruling Out Malignancy","volume":"15","author":"Keirns","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.ejim.2025.04.034_bib0147","first-page":"S17","article-title":"Non-steroidal anti-inflammatory drugs and the continuum of renal dysfunction","volume":"20","year":"2002","journal-title":"J Hypertens"},{"issue":"6","key":"10.1016\/j.ejim.2025.04.034_bib0148","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1210\/endrev\/bnae023","article-title":"Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement","volume":"45","author":"Karavitaki","year":"2024","journal-title":"Endocr Rev."},{"issue":"21","key":"10.1016\/j.ejim.2025.04.034_bib0149","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.2146\/ajhp150208","article-title":"A probable case of syndrome of inappropriate antidiuretic hormone secretion associated with linezolid","volume":"72","author":"Baik","year":"2015","journal-title":"American Journal of Health-System Pharmacy"},{"issue":"3","key":"10.1016\/j.ejim.2025.04.034_bib0150","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2146\/ajhp110201","article-title":"Syndrome of inappropriate antidiuretic hormone associated with moxifloxacin","volume":"69","author":"Yam","year":"2012","journal-title":"Am J Health Syst Pharm"},{"issue":"6","key":"10.1016\/j.ejim.2025.04.034_bib0151","doi-asserted-by":"crossref","first-page":"e684","DOI":"10.1097\/MJT.0000000000000642","article-title":"Syndrome of Inappropriate Antidiuretic Hormone Consecutive to treatment with Ciprofloxacin","volume":"25","author":"Kumar","year":"2018","journal-title":"Am J Ther"},{"issue":"4","key":"10.1016\/j.ejim.2025.04.034_bib0152","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrneph.2009.17","article-title":"Fluid, electrolyte and acid-base disorders associated with antibiotic therapy","volume":"5","author":"Zietse","year":"2009","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"10.1016\/j.ejim.2025.04.034_bib0153","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/j.1875-9114.1997.tb03674.x","article-title":"Mirtazapine: an antidepressant with noradrenergic and specific serotonergic effects","volume":"17","author":"Stimmel","year":"1997","journal-title":"Pharmacotherapy"},{"issue":"5","key":"10.1016\/j.ejim.2025.04.034_bib0154","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/00048670701261202","article-title":"Venlafaxine hyponatraemia: incidence, mechanism and management","volume":"41","author":"Roxanas","year":"2007","journal-title":"Aust N Z J Psychiatry"},{"issue":"4","key":"10.1016\/j.ejim.2025.04.034_bib0155","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/00007611-197404000-00027","article-title":"The syndrome of inappropriate secretion of antidiuretic hormone associated with amitriptyline administration","volume":"67","author":"Luzecky","year":"1974","journal-title":"South Med J"},{"key":"10.1016\/j.ejim.2025.04.034_bib0156","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-014-0231-1","article-title":"Diagnosis and treatment of hyponatremia: a systematic review of clinical practice guidelines and consensus statements","volume":"12","author":"Nagler","year":"2014","journal-title":"BMC Med"},{"issue":"Suppl 4","key":"10.1016\/j.ejim.2025.04.034_bib0157","doi-asserted-by":"crossref","first-page":"41","DOI":"10.7861\/clinmed.22-4-s41","article-title":"Amlodipine induced hyponatraemia","volume":"22","author":"Tun","year":"2022","journal-title":"Clin Med (Lond)"},{"issue":"5","key":"10.1016\/j.ejim.2025.04.034_bib0158","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1159\/000471493","article-title":"Thiazide-Associated Hyponatremia, Report of the Hyponatremia Registry: An Observational Multicenter International Study","volume":"45","author":"Burst","year":"2017","journal-title":"Am J Nephrol"},{"issue":"12","key":"10.1016\/j.ejim.2025.04.034_bib0159","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.1093\/ndt\/gfq317","article-title":"Carbamazepine can induce kidney water absorption by increasing aquaporin 2 expression","volume":"25","author":"de Braganca","year":"2010","journal-title":"Nephrol Dial Transplant"},{"issue":"9230","key":"10.1016\/j.ejim.2025.04.034_bib0160","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S0140-6736(00)02613-1","article-title":"Hyponatraemia associated with lamotrigine in cranial diabetes insipidus","volume":"356","author":"Mewasingh","year":"2000","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ejim.2025.04.034_bib0161","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4103\/1817-1745.84422","article-title":"Lamotrigine-induced SIADH in a child with central diabetes insipidus","volume":"6","author":"Kilic","year":"2011","journal-title":"J Pediatr Neurosci"},{"issue":"3","key":"10.1016\/j.ejim.2025.04.034_bib0162","doi-asserted-by":"crossref","first-page":"302","DOI":"10.4103\/aian.aian_996_22","article-title":"Recurrent Hyponatremia: Levetiracetam - An Uncommon Cause","volume":"26","author":"Gattu","year":"2023","journal-title":"Ann Indian Acad Neurol"},{"issue":"4","key":"10.1016\/j.ejim.2025.04.034_bib0163","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.seizure.2007.10.007","article-title":"Levetiracetam-associated hyponatremia","volume":"17","author":"Belcastro","year":"2008","journal-title":"Seizure"},{"issue":"1","key":"10.1016\/j.ejim.2025.04.034_bib0164","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/14740338.2017.1248399","article-title":"Hyponatremia induced by antiepileptic drugs in patients with epilepsy","volume":"16","author":"Lu","year":"2017","journal-title":"Expert Opin Drug Saf"},{"issue":"9","key":"10.1016\/j.ejim.2025.04.034_bib0165","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.medcli.2009.07.007","article-title":"[Levetiracetam-associated hyponatremia]","volume":"135","author":"C\u00f3rdoba L\u00f3pez","year":"2010","journal-title":"Med Clin (Barc)"},{"issue":"3","key":"10.1016\/j.ejim.2025.04.034_bib0166","doi-asserted-by":"crossref","first-page":"284","DOI":"10.5543\/tkda.2015.45735","article-title":"The first case of levetiracetam-induced and tolvaptan-resistant hyponatremia","volume":"43","author":"Ar\u0131","year":"2015","journal-title":"Turk Kardiyol Dern Ars"},{"issue":"1","key":"10.1016\/j.ejim.2025.04.034_bib0167","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s13760-017-0825-4","article-title":"Levetiracetam-induced hyponatremia","volume":"118","author":"Rosca","year":"2018","journal-title":"Acta Neurol Belg"},{"issue":"5","key":"10.1016\/j.ejim.2025.04.034_bib0168","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/ana.10190","article-title":"Effects of oxcarbazepine on sodium concentration and water handling","volume":"51","author":"Sachdeo","year":"2002","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.ejim.2025.04.034_bib0169","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/107424840200700i104","article-title":"Syndrome of inappropriate antidiuretic hormone secretion (SIADH) induced by amiodarone: a report on two cases","volume":"7","author":"Ikegami","year":"2002","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.ejim.2025.04.034_bib0170","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2165\/11318950-000000000-00000","article-title":"Syndrome of inappropriate antidiuretic hormone secretion (SIADH) or hyponatraemia associated with valproic Acid: four case reports from the Netherlands and a case\/non-case analysis of vigibase","volume":"33","author":"Beers","year":"2010","journal-title":"Drug Saf"},{"issue":"4","key":"10.1016\/j.ejim.2025.04.034_bib0171","doi-asserted-by":"crossref","first-page":"430","DOI":"10.15386\/mpr-2368","article-title":"Identification of risk factors associated with hyponatremia in psychiatric patients: a case-control study","volume":"95","author":"Powle","year":"2022","journal-title":"Med Pharm Rep"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095362052500175X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095362052500175X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T10:14:58Z","timestamp":1762337698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095362052500175X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":171,"alternative-id":["S095362052500175X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2025.04.034","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug-induced hyponatremia in clinical care","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2025.04.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Federation of Internal Medicine.","name":"copyright","label":"Copyright"}]}}